[CHM] QoQ Quarter Result on 30-Sep-2022 [#Q1]

Stock
[CHM] Chimeric Therapeutics Limited
Announcement Date
29-Sep-2022
Financial Year
2023
Quarter
30-Sep-2022 [#Q1]
Profit Trend
QoQ- 5.40%
YoY- -21.26%
Quarter Report
CHM's Result
CHM's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 706 706 1,505 1,505 1,309 1,309 0 -
PBT -15,592 -7,090 -14,737 -5,822 -6,046 -3,023 -9,689 37.44%
Tax -1,423 6 -2,990 52 164 82 4,574 -
NP -14,169 -7,085 -11,748 -5,874 -6,209 -3,105 -9,689 28.92%
Tax Rate - - - - - - - -
Total Cost 14,875 7,790 13,252 7,379 7,518 4,413 9,689 33.18%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -2,007.51 -1,003.76 -780.61 -390.30 -474.53 -237.26 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.03 -0.02 -0.03 -0.01 -0.02 -0.01 -0.03 0.00%
EPS Diluted -0.03 -0.02 -0.03 -0.01 -0.02 -0.01 -0.03 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.